An AI system can identify high-risk areas on interval breast cancer screening mammograms and detect tumours that radiologists miss, a Swiss study shows. Medscape News UK
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
GAE reduces pain biomarkers in knee osteoarthritis
Genicular artery embolization (GAE) significantly reduces key biomarkers that drive pain in patients with knee osteoarthritis.
-
Race, ethnicity influence educational debt among radiology-bound MDs
Graduates from racial and ethnic groups underrepresented in medicine had a higher likelihood of debt, according to a recent study…
-
Emerging Trends with Burnout in Radiology: An Interview with Chris Mattern, MD, Part 2
In the second part of a recent interview, Chris Mattern. M.D., discussed the increasing burden of non-clinical tasks upon radiologist workloads and the potential of the emerging enterprise imaging platform MosaicOS to address efficiency and restore the focus on clinical care.
-
Radiological T-staging in prostate Cancer: Towards a universal MRI-based scoring system
Magnetic resonance imaging (MRI) has transformed prostate cancer diagnosis by enhancing lesion detection, guiding targeted biopsies, and reducing unnecessary procedures [1–3]. Despite these advancements, MRI performance in tumor (T) staging remains variable, particularly in distinguishing organ-confined (T2) from locally advanced (T3a) disease. Accurate radiological assessment of extraprostatic extension poses persistent challenges [4], exposing patients to the risk of both undertreatment and ov…
-
AI-Digital Pathology Software for Prostate Cancer Care Receives FDA De Novo Marketing Authorization
tim.hodson
Thu, 08/14/2025 – 16:54
Aug. 13, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, recently announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI Prostate, establishing it as the first and only AI-powered software authorized to prognosticate long-term outcomes for patients with non-metastatic prostate cancer.
ArteraAI Prostate is now recognized as an … -
Philips to Invest in Manufacturing, R&D in the U.S. to Expand Production of AI-powered Health Technology
tim.hodson
Thu, 08/14/2025 – 13:33
Aug. 14, 2025 — Philips has announced a plan for new investments of more than $150 million in U.S. manufacturing and research and development (R&D). Philips also unveiled the expansion of its Reedsville, PA, manufacturing facility, which produces AI-enabled ultrasound systems for hospitals across the U.S.
These investments come on top of Philips’ annual $900 million R&D investment in the U.S. as well as investments in nearly 17,000 collea… -
FDA Panel Concerned Dermal Fillers Could Impact Breast Cancer Screening
(MedPage Today) — The FDA’s outside experts on Wednesday weighed in on the potential risks of dermal fillers for the décolletage area, particularly in regards to possible interference with breast cancer screening and imaging, and how these…
-
FDA Clears Upgrade of 3T MRI System for the Operating Suite
Incorporating technology from Siemens Healthineers’ Magnetom Skyra Fit system, the Invision 3T Recharge Operating Suite offers AI-powrred protocols and automated image reconstruction capabilities.
-
Researchers Perform Minimally Invasive Procedure to Relieve Knee Osteoarthritis Pain
tim.hodson
Thu, 08/14/2025 – 11:44
Aug. 14, 2025 — An interventional radiologist at NYU Langone Health recently performed a procedure to relieve a patient’s chronic knee pain caused by osteoarthritis. The procedure was performed in less than two hours while the patient was mildly sedated.
As they gradually break down, knee joints in people with osteoarthritis are known to become inflamed, which triggers the growth of small blood vessels (angiogenesis) and increased blood flow to j…